Medtech Insights

Although the poor economic conditions in Latin America continue to create downward pricing pressures and hinder the adoption of premium-priced products such as advanced energy devices, the Latin…

he European varicose vein treatment device market will be characterized by shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which…

The Asia Pacific vascular access device market will grow moderately through 2027, driven by an expanding patient population and increasing adoption of premium-priced devices. This Medtech 360…

The global therapeutic BTX market will grow strongly through 2027, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving…

The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of PICCs in all European countries, as well as the…

Ongoing economic recovery in Europe and the growing availability of low cost products are making dental implant procedures more accessible across the region, supporting market growth that will…

The US trauma device market will grow at a moderate rate through 2027, driven primarily by favorable demographics, increasing penetration into existing eligible patient populations, improved…

The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of PICCs in all European countries, as well as the…

The US market for TEO devices is dynamic and complex, driven by continual device improvement and adoption of new, innovative products. This Medtech 360 Report provides comprehensive data and…

The US TEO device market is a dynamic and complex space, characterized by frequent product launches and numerous clinical trials. Procedure volume growth will be driven by continual product…

The Latin American heart valve device market will experience robust growth, largely driven by an expanding patient pool, improving access to treatment, and rising adoption of THV devices through…

The US heart valve device market is large and growing, driven by the continued adoption and launch of THV devices, as well as an aging population. The accumulation of positive clinical trial…